OncoVista Innovative Therapies, Inc. Appoints J. Michael Edwards New Chief Financial Officer

SAN ANTONIO--(BUSINESS WIRE)--OncoVista Innovative Therapies, Inc. (OTC BB: AVUG) announced the appointment of J. Michael Edwards as Chief Financial Officer of the Company effective January 2, 2008. Mr. Edwards brings fifteen years of experience in financial management and leadership, with almost seven years in healthcare-related companies, to his new role at OncoVista.

MORE ON THIS TOPIC